PROCEPT BioRobotics Corp PRCT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $79.29
- Day Range
- $78.52–80.61
- 52-Week Range
- $24.83–85.81
- Bid/Ask
- $78.52 / $80.44
- Market Cap
- $4.13 Bil
- Volume/Avg
- 313,082 / 667,374
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 22.70
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 626
Comparables
Valuation
|
Metric
|
PRCT
|
688277
|
LUNG
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 16.39 | 2.74 | 3.21 |
Price/Sales | 22.70 | 17.66 | 4.17 |
Price/Cash Flow | — | — | — |
Price/Earnings
PRCT
688277
LUNG
Financial Strength
|
Metric
|
PRCT
|
688277
|
LUNG
|
|---|---|---|---|
Quick Ratio | 6.37 | 2.11 | 7.75 |
Current Ratio | 7.51 | 2.75 | 8.97 |
Interest Coverage | −26.05 | −15.62 | −16.66 |
Quick Ratio
PRCT
688277
LUNG
Profitability
|
Metric
|
PRCT
|
688277
|
LUNG
|
|---|---|---|---|
Return on Assets (Normalized) | −20.90% | −13.35% | −21.96% |
Return on Equity (Normalized) | −30.98% | −17.03% | −33.26% |
Return on Invested Capital (Normalized) | −25.33% | −14.15% | −25.19% |
Return on Assets
PRCT
688277
LUNG
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Hphvcsnh | Yxmpyz | $195.6 Bil | |||
| Stryker Corp
SYK
| Zszpbhhb | Rrgf | $137.3 Bil | |||
| Boston Scientific Corp
BSX
| Cspfqdvc | Rmtcctd | $122.7 Bil | |||
| Medtronic PLC
MDT
| Brfzcjqgv | Dgcmmsh | $114.6 Bil | |||
| Edwards Lifesciences Corp
EW
| Kcdywrmygj | Pfprry | $40.1 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Dzbj | Jcsz | $30.7 Bil | |||
| DexCom Inc
DXCM
| Lrtpsvtk | Jjhy | $27.0 Bil | |||
| Steris PLC
STE
| Jlfdnrt | Htvfdbn | $23.6 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Bwbdbdjjyp | Rghb | $22.0 Bil | |||
| Insulet Corp
PODD
| Crwfqrvq | Qwmhdy | $16.3 Bil |
United States